𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increased myocardial contractility and improved glycaemic control

✍ Scribed by A. D. B. Harrower; L. Thuesen; J. Sandahl Christiansen


Publisher
Springer
Year
1986
Tongue
English
Weight
254 KB
Volume
29
Category
Article
ISSN
0012-186X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Breaking the barriers for improved glyca
✍ Rhys Williams πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 2 views

The prevalence of diabetes is predicted to increase dramatically over the next 30 years, mostly as a result of Type 2 diabetes. To manage this increased burden, the following measures must be implemented: diabetes care must be delivered in the most suitable locations; people with diabetes must remai

Weight reduction and improved glycaemic
✍ Dalvi, S ;Khanolkar, M ;Biswas, M πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 463 KB

## Abstract Post‐menopausal oestrogen deficiency symptoms may cause mood disturbances and affect compliance, yet clinicians are reluctant to prescribe oestrogen replacement in view of adverse risks. A 51‐year‐old woman was referred with poor glycaemic control. Compliance with diet and medications

Vigabatrin increases human brain homocar
✍ Dr. Ognen A. C. Petroff; Richard H. Mattson; Kevin L. Behar; Fahmeed Hyder; Doug πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 521 KB

Homocarnosine, a dipeptide of gamma-aminobutyric acid (GABA) and histidine, is thought to be an inhibitory neuromodulator synthesized in subclasses of GABAergic neurons. Homocarnosine is present in human brain in greater amounts (0.4-1.0 micromol/g) than in other animals. The antiepileptic drug viga

Troglitazone, an insulin action enhancer
✍ Kumar, S.; Prange, A.; Schulze, J.; Lettis, S.; Barnett, A.H. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 107 KB πŸ‘ 2 views

The management of Type 2 diabetes mellitus with currently available oral agents may be complicated in the elderly by an increased frequency of side-effects. The effects of troglitazone, an insulin action enhancer, were studied in elderly patients with Type 2 diabetes in a double-blind, parallel-grou